The Clinical Trials Unit

The Clinical Trials Unit offers children, adolescents, and adults diagnosed with a wide range of psychiatric disorders an opportunity to participate in innovative research and clinical trials.

Our team of experienced psychiatrists and clinicians promotes excellence in clinical care through cutting edge research on the latest medications and novel therapeutic options in hopes of improving patient outcomes and quality of life.

Staff | Overview | Participate in a Clinical Trial | Active Clinical Trials | Upcoming

Join our Research Registry

If you are interested in participating in research at the Clinical Trials Unit follow the link below to sign up for our research registry. This will allow us to contact you for current and future research opportunities at the CTU. If you have any questions, email or call 860.545.7476.

Click here to join

Current Staff

  • Director: Benjamin Anderson, MD
  • Supervisor: Sara Putala, BA
  • Clinical Research Associate: Megan Calderado, LMFT
  • Clinical Research Assistant: Bruno Casanova, MS
  • Clinical Research Assistant: Fiza Malik, BA
  • Investigator: Tonya Ruggieri, MD


Psychiatric clinical trials are highly regulated research studies using human volunteers to test the safety and efficacy of novel psychiatric drugs and treatments. Clinical trials are essential for developing new methods to prevent, diagnose, and treat psychiatric disorders. By participating in a clinical trial, patients can take an active role in managing their symptoms, gain access to novel research treatments before they are widely available, and help others by advancing our scientific understanding of the causes and contributors of psychiatric conditions.


The Clinical Trials Unit is located on the Hartford Hospital / Institute of Living campus in Hartford, CT. The service, directed by Dr. Benjamin Anderson, conducts controlled, clinical testing in human subjects of investigational psychiatric drugs, therapeutic modalities, or combined treatments that are currently in development but not yet approved for use in routine clinical care. Investigational drugs and/or treatments can only be administered to eligible individuals who are enrolled in a formal research study.

All research and clinical studies at the Clinical Trials Unit are conducted under investigator-initiated or industry-sponsored protocols with financial support from pharmaceutical companies, government agencies, and/or non-profit entities. The Hartford Healthcare Institutional Review Board, in conjunction with study sponsors and regulatory authorities, reviews, approves, and oversees all research and clinical trials at the Clinical Trials Unit.

Below you can find more information about currently running research and clinical trials and participant eligibility criteria. If you or a loved one are interested in participating in a research or clinical trial, please contact us by calling 860.545.7476.

Participate in a Clinical Trial

Our current and upcoming studies are listed below. For more information or to see if you or your loved one are eligible to participate in an ongoing or upcoming study, please email us at or call us 860-545-7476. We look forward to hearing from you.

Active Clinical Trials

Now Recruiting



Has your child recently been diagnosed with schizophrenia or bipolar I disorder? They may be eligible for this study!

This is a clinical study to assess weight gain in pediatric patients with schizophrenia and bipolar I disorder after treatment with olanzapine and samidorphan.

Qualified participants include:

  • Children/Teens ages 10-17
  • Have been diagnosed with schizophrenia or bipolar I disorder
  • Patients who have recently started treatment with olanzapine, are currently experiencing an inadequate response to an antipsychotic or had an inadequate response to at least 1 antipsychotic medication in the past

Those that qualify will:

  • Receive study-related care and medications at no cost
  • Reimbursement for travel or other expenses may be provided

For more information, contact or call us 860.545.7476

Now Recruiting



Have you been diagnosed with schizophrenia and are experiencing negative symptoms? This study may be for you! 

This is a research study to assess the safety and efficacy of a digital therapeutic in adults with negative symptoms of schizophrenia. 

Qualified participants include:

  • Adults ages 18 and older
  • Have been diagnosed with schizophrenia
  • Are on a stable dose of antipsychotic medication(s) for at least 12 weeks

Those that qualify will:

  • Receive study-related care at no cost
  • Reimbursement for travel or other expenses may be provided

For more information, contact or call us 860.545.7476

Upcoming Clinical Trials

Coming Soon

No upcoming clinical trials.

Check back again soon!

Back to Top

Contact the Clinical Trials Unit

Contact the Clinical Trials Unit